U.S. Markets closed
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • Dow 30

    35,677.02
    +73.94 (+0.21%)
     
  • Nasdaq

    15,090.20
    -125.50 (-0.82%)
     
  • Russell 2000

    2,291.27
    -4.91 (-0.21%)
     
  • Gold

    1,793.60
    +11.70 (+0.66%)
     
  • EUR/USD

    1.1648
    +0.0018 (+0.1514%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • Vix

    15.43
    +0.42 (+2.80%)
     
  • GBP/USD

    1.3759
    -0.0036 (-0.2628%)
     
  • USD/JPY

    113.4600
    -0.5280 (-0.4632%)
     
  • BTC-USD

    60,734.92
    -2,040.60 (-3.25%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • Nikkei 225

    28,804.85
    +96.25 (+0.34%)
     

Why MSO Uplistings Could Be The Next Major Cannabis Stock Catalyst

·2 min read

Optimism surrounding timely U.S. federal cannabis legalization by Democrats in Washington has faded throughout 2021, and so too have early-year gains among many popular cannabis stocks. In fact, the ETFMG Alternative Harvest ETF (NYSE: MJ), which was once up more than 120% year-to-date, recently crossed over to a negative return for the year.

Despite the recent weakness, Cantor Fitzgerald cannabis analyst Pablo Zuanic said Wednesday that he still likes the setup for U.S. multi-state cannabis operators ahead of potential stock uplistings to major U.S. exchanges.

Related Link: Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics'

Potential Reform Compromise? Earlier this month, Senator Elizabeth Warren and Senator Cory Booker sent a letter to the Department of Justice urging it to decriminalize cannabis. The letter contained a deadline for action of Oct. 20.

On Wednesday, Zuanic said he believes Democrats are willing to compromise on cannabis reform, potentially settling for federal decriminalization rather than legalization.

Meanwhile, the business fundamentals for U.S. MSO stocks continue to improve, while the stocks have collectively lost about half their value since February peaks.

Institutional Buying Power: Since MSOs are not allowed to trade on major exchanges like the Nasdaq and the NYSE and technically run federally illegal businesses, most institutional investors will not touch them. In fact, retail investors currently account for about 95% of MSOs free float, Zuanic said.

However, he said there are several ways the path could be cleared for U.S. MSOs to uplist to major exchanges, potentially opening the door for major institutional buying.

“Yes, we consider this a good entry point, and would expect the entire US group to trade up, if our thesis is proven correct,” Zuanic said.

He added that institutional investors will likely be more discerning than retail traders, suggesting MSO stock selection may be more important moving forward.

Zuanic's top MSO stock picks are Overweight-rated Curaleaf Holdings Inc (OTC: CURLF), Green Thumb Industries Inc (OTC: GTBIF) and Trulieve Cannabis Corp (OTC: TCNNF).

Benzinga’s Take: Cannabis investors should have learned by now that any kind of legislative progress in Washington is always excruciatingly slower than it should be. In the meantime, cannabis stocks will likely continue to be extremely volatile, and long-term investors should take a diversified approach to the space to help mitigate risk.

Latest Ratings for CURLF

Oct 2021

Needham

Maintains

Buy

Mar 2021

Cantor Fitzgerald

Maintains

Overweight

Mar 2021

Needham

Maintains

Buy

View More Analyst Ratings for CURLF
View the Latest Analyst Ratings

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.